Immunity and vaccines for cryptosporidiosis

Clicks: 3
ID: 338491
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #497 of 503 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 503 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Cryptosporidiosis contributes significantly to global morbidity and mortality, particularly among children <2 years old in resource-poor countries. Host immunity is critical in limiting infection, and natural Cryptosporidium infection confers protection against subsequent disease, suggesting that effective vaccination is biologically achievable. Both innate and adaptive immune responses are important in clearing and preventing infection. Therefore, an ideal vaccine would stimulate both innate and adaptive immune responses, including those in the intestinal mucosa.
Reference Key
openalex_W7225186939 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sara M. Dann, Arthur Clinton White, Alejandro Castellanos-González
Are you one of these authors? Claim your profile
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag539
URL
https://doi.org/10.1093/infdis/jiag539
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.